- 专利标题: IRIDIUM (III) COMPLEXES CONTAINING N-HETEROCYCLIC CARBENE LIGAND, SYNTHESIS, AND THEIR USE THEREOF IN CANCER TREATMENT
-
申请号: US17264719申请日: 2019-07-31
-
公开(公告)号: US20210317153A1公开(公告)日: 2021-10-14
- 发明人: Chi Ming Che , Tsz Lung Lam , Ka Chung Tong
- 申请人: The University of Hong Kong
- 申请人地址: CN Hong Kong
- 专利权人: The University of Hong Kong
- 当前专利权人: The University of Hong Kong
- 当前专利权人地址: CN Hong Kong
- 国际申请: PCT/CN2019/098542 WO 20190731
- 主分类号: C07F15/00
- IPC分类号: C07F15/00 ; A61N5/06 ; A61P35/00
摘要:
Provided herein are Ir(III) complexes comprising N-heterocyclic carbene ligand, method of synthesis of the Ir(III) complexes, a pharmaceutical composition comprises thereof. Also provided herein are the methods for the treatment and prevention of cancer/tumor in patients in need thereof by the administration of the Ir(III) complexes under both dark and light conditions. Also provided is a method of detecting the Ir(III) complex in a biological system. Also provided is a method of making the Ir(III) complex. The Ir(III) complexes possess anticancer activity such as the induction of cell death, inhibition of cellular proliferation, and inhibition of tumor growth in vivo.
公开/授权文献
信息查询